Monica Musteanu

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 4

Top Topics

Epithelial Mesenchymal Transition

Advanced Non Small Cell Lung Cancer

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Fernando Fernández-García, Ana Fernández-Rodríguez, Coral Fustero-Torre, Elena Piñeiro-Yañez, Haiyun Wang, Carmen G Lechuga, Sergio Callejas, Rebeca Álvarez, Alejandra López-García, Laura Esteban-Burgos, Marina Salmón, Marta San Román, Carmen Guerra, Chiara Ambrogio, Matthias Drosten, David Santamaría, Fátima Al-Shahrour, Ana Dopazo, Mariano Barbacid, Monica Musteanu
Type I interferon signaling pathway enhances immune-checkpoint inhibition in KRAS mutant lung tumors. Proceedings of the National Academy of Sciences of the United States of America 121 (36) (2024)
Fernando Fernández-García, Ana Fernández-Rodríguez, Coral Fustero-Torre, Elena Piñeiro-Yañez, Haiyun Wang, Carmen G Lechuga, Sergio Callejas, Rebeca Álvarez, Alejandra López-García, Laura Esteban-Burgos, Marina Salmón, Marta San Román, Carmen Guerra, Chiara Ambrogio, Matthias Drosten, David Santamaría, Fátima Al-Shahrour, Ana Dopazo, Mariano Barbacid, Monica Musteanu
Type I interferon signaling pathway enhances immune-checkpoint inhibition in KRAS mutant lung tumors. Proceedings of the National Academy of Sciences of the United States of America 121 (36) (2024)
Marina Salmón, Guillem Paniagua, Carmen G Lechuga, Fernando Fernández-García, Eduardo Zarzuela, Ruth Álvarez-Díaz, Monica Musteanu, Carmen Guerra, Eduardo Caleiras, Javier Munoz, Sagrario Ortega, Matthias Drosten, Mariano Barbacid
KRAS4A induces metastatic lung adenocarcinomas in vivo in the absence of the KRAS4B isoform. Proceedings of the National Academy of Sciences of the United States of America 118 (30) (2021)
Herwig P Moll, Klemens Pranz, Monica Musteanu, Beatrice Grabner, Natascha Hruschka, Julian Mohrherr, Petra Aigner, Patricia Stiedl, Luka Brcic, Viktoria Laszlo, Daniel Schramek, Richard H Moriggl, Robert Eferl, Judit Moldvay, Katalin Dezso, Pedro P López-Casas, Dagmar Stoiber, Manuel Hidalgo, Josef M Penninger, Maria Sibilia, Balázs Győrffy, Mariano Barbacid, Balázs Dome, Helmut H Popper, Emilio Casanova
Afatinib restrains K-RAS-driven lung tumorigenesis. Science translational medicine 10 (446) (2019)